Pages that link to "Q41946175"
Jump to navigation
Jump to search
The following pages link to Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension. (Q41946175):
Displaying 50 items.
- Functional changes in pulmonary arterial endothelial cells associated with BMPR2 mutations (Q24303490) (← links)
- Targeting BMP signalling in cardiovascular disease and anaemia (Q26783734) (← links)
- BMPR2 spruces up the endothelium in pulmonary hypertension (Q26786834) (← links)
- BMPs and their clinical potentials (Q26824827) (← links)
- Coagulation and the vessel wall in pulmonary embolism (Q27021049) (← links)
- Enhanced responses to angiogenic cues underlie the pathogenesis of hereditary hemorrhagic telangiectasia 2 (Q28487916) (← links)
- Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension (Q28534831) (← links)
- Bmp2 and Bmp4 exert opposing effects in hypoxic pulmonary hypertension (Q28863843) (← links)
- Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia (Q30491276) (← links)
- A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects (Q30544892) (← links)
- Pulmonary arterial hypertension: the clinical syndrome (Q30583630) (← links)
- BMP-9 induced endothelial cell tubule formation and inhibition of migration involves Smad1 driven endothelin-1 production (Q31047574) (← links)
- MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension (Q32884516) (← links)
- Three novel BMPR2 mutations associated with advanced pulmonary arterial hypertension (Q33580827) (← links)
- Endothelial follistatin-like-1 regulates the postnatal development of the pulmonary vasculature by modulating BMP/Smad signaling. (Q33738647) (← links)
- Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertension (Q33806083) (← links)
- Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies (Q33849207) (← links)
- Role of somatic mutations in vascular disease formation (Q34059841) (← links)
- Targeting the vasoprotective axis of the renin-angiotensin system: a novel strategic approach to pulmonary hypertensive therapy (Q34215319) (← links)
- Arterial wall stress controls NFAT5 activity in vascular smooth muscle cells (Q34297089) (← links)
- ID family protein expression and regulation in hypoxic pulmonary hypertension (Q34429113) (← links)
- Bone Morphogenetic Protein (BMP) signaling in development and human diseases (Q34512444) (← links)
- Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension (Q34958933) (← links)
- Physiologic and molecular consequences of endothelial Bmpr2 mutation (Q35121379) (← links)
- Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival (Q35187029) (← links)
- Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner (Q35235680) (← links)
- Protein Trafficking Dysfunctions: Role in the Pathogenesis of Pulmonary Arterial Hypertension (Q35412349) (← links)
- The genetics of pulmonary arterial hypertension in the post-BMPR2 era. (Q35573919) (← links)
- Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension. (Q35832692) (← links)
- Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension (Q35850320) (← links)
- Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2( /-) Mice with Schistosomiasis. (Q36516808) (← links)
- Hereditary spastic paraplegia-causing mutations in atlastin-1 interfere with BMPRII trafficking (Q36653382) (← links)
- Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects (Q36769101) (← links)
- In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug (Q36869381) (← links)
- The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice. (Q36878827) (← links)
- Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension (Q36888302) (← links)
- Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiation (Q36934968) (← links)
- FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. (Q37052894) (← links)
- SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension (Q37087816) (← links)
- Baroreflex activation for the treatment of heart failure (Q37200514) (← links)
- Cellular and molecular basis of pulmonary arterial hypertension (Q37465320) (← links)
- Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization. (Q37474984) (← links)
- Role of gremlin in the lung: development and disease (Q37539508) (← links)
- Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension (Q37576723) (← links)
- Implication of overexpression of dishevelled-associated activator of morphogenesis 1 (Daam-1) for the pathogenesis of human Idiopathic Pulmonary Arterial Hypertension (IPAH). (Q37697819) (← links)
- BMP signaling in vascular development and disease (Q37776859) (← links)
- Vascular development: genetic mechanisms and links to vascular disease (Q37778482) (← links)
- Viruses in Pharmaceutical Research: Pulmonary Vascular Disease (Q37817455) (← links)
- Gene therapy for pulmonary hypertension: prospects and challenges (Q37827155) (← links)
- The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension (Q37854945) (← links)